Reporting, access, and transparency: Better infrastructure of clinical trials

Critical Care Medicine

Volumn 37, Issue SUPPL. 1, 2009, Pages

  Antonelli, Massimo ^a   Mercurio, Giovanna ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Access; Bias; Clinical trial; Funds; Government; Industries; Information; Partnership; Reporting

Indexed keywords

CLINICAL PRACTICE; CLINICAL STUDY; CLINICAL TRIAL; DATA BASE; DRUG INDUSTRY; EDITOR; FINANCIAL MANAGEMENT; GOVERNMENT REGULATION; HEALTH CARE INDUSTRY; HEALTH CARE ORGANIZATION; HISTORY; HUMAN; INFORMATION PROCESSING; INTERNET; LAW; MEDICAL EDUCATION; MEDICAL INFORMATICS; MEDICAL RESEARCH; METHODOLOGY; PRIORITY JOURNAL; PRODUCTIVITY; PUBLIC HEALTH; PUBLISHING; QUALITY CONTROL; REGISTER; REGISTRATION; REVIEW; SYSTEMATIC ERROR; WORLD HEALTH ORGANIZATION; ARTICLE; STANDARD;

CLINICAL TRIALS AS TOPIC; HUMANS; PUBLICATION BIAS; PUBLISHING; REGISTRIES;

EID: 58849142158     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31819207bb     Document Type: Article

References (43)

1. De Angelis CD, Drazen JM, Frizelle FA, et al: Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. N Engl J Med 2005; 352:2436-2438
2. Scherer RW, Langenberg P: Full publication of results initially presented in abstracts [Cochrane Methodology Review]. Oxford, England: Cochrane Library, Update Software; 2003; issue 1
3. Missing drug data. Washington Post June 30, 2004:A20
4. When drug companies hide data. New York Times June 6, 2004 (Sect 4):12
5. Chalmers I: Underreporting research is scientific misconduct. JAMA 1990; 263: 1405-1408
6. Miller FG, Brody H: Professional integrity industry-sponsored clinical trials. Acad Med 2005; 80:899-904
7. Institute of Medicine urges reforms at FDA [editorial]. Lancet 2006; 368:1211
8. Zarin DA, Tse T, Ide NC: Trial registration at ClinicalTrials.gov between May and October 2005. N Engl J Med 2005; 353:2779-2787
9. Krleza-Jeric K, Chan A-W, Dickersin K, et al: Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1). BMJ 2005; 330:956-958
10. Korn D, Ehringhaus S: Principles for strengthening the integrity of clinical research. PLoS Clin Trials 2006; 1:e1
11. Bayer's duplicity on drug safety. New York Times October 4, 2006 (Sect A):30
12. Enhancing drug safety and innovation act of 2006, Stat 3807
13. European Clinical Trials Directive (Directive 2001/20/EC)
14. Smith R, Roberts I: An amnesty for unpublished trials. BMJ 1997; 315:622
15. Roberts I: One year on many trials are unregistered and the amnesty remains open. BMJ 1998; 317:763-764
16. Food and Drug Administration Modernization Act of 1997, Pub. L. 105-115, 113, information program on clinical trials for serious or life-threatening diseases
17. Available at: http:// www.clinicaltrials.gov. Accessed December 2007
18. Tonks A: A clinical trials register for Europe. BMJ 2002; 325:1314-1315
19. Available at: http:// www.controlled-trials.com. Accessed December 2007
20. De Angelis C, Drazen JM, Frizelle FA, et al: Clinical trial registration: A statement from the International Committee of Medical Journal Editors. N Engl J Med 2004; 351:1250-1251
21. Gü lmezoglu AM, Pang T, Horton R, et al: WHO facilitates international collaboration in setting standards for clinical trial registration. Lancet 2005; 365:1829-1831
22. WHO. International Clinical Trials Registry Platform. Trial registration data set. Available at: http:// www.who.int/ictrp/data-set/ en/index1.html. Accessed December 2007
23. Available at: http:// www.clinicalstudyresults.org. Accessed December 2007
24. Djulbegovic B, Lacevic M, Cantor A, et al: The uncertainty principle and industry-sponsored research. Lancet 2000; 356:635-638
25. Yaphe J, Edman R, Knishkowy B, et al: The association between funding by commercial interests and study outcome in randomized controlled drug trials. Fam Pract 2001; 18: 565-568
26. Kjaergard LL, Als-Nielsen B: Association between competing interests and authors' conclusions: Epidemiological study of randomised clinical trials published in BMJ. BMJ 2002; 325:249-252
27. Als-Nielsen B, Chen W, Gluud C, et al: Asso-randomized drug trials: A reflection of treatment effect or adverse events? JAMA 2003; 290:921-928
28. Nieto A, Mazon A, Pamies R, et al: Adverse effects of inhaled corticosteroids in funded and nonfunded studies. Arch Intern Med 2007; 167:2047-2053
29. Zarin DA, Keselman A: Registering a clinical trial in ClinicalTrials.gov. Chest 2007; 131:909 -912
30. Drazen JM, Zarin DA: Salvation by registration. N Engl J Med 2007; 356:184-185
31. Sim I, Chan AW, Gü lmezoglu AM, et al: Clinical trial registration: Transparency is the watchword. Lancet 2006; 367:1631-1633
32. 2007 Update of the NHS Trusts Clinical Trials Register. Available at: http://www.controlledtrials. com/mrct. Accessed December 2007
33. 2007 Annual report. Available at: http:// www.phrma.org/files/2007% 20Annual%20 Report.pdf. Accessed December 2007
34. National Institute of Health: Summary of the FY 2006 President's Budget.Available at: http://grants.nih.gov/grants/financial/ index.htm#Res07. Accessed December 2007
35. Singer EA, Druml C: Compulsory registration of clinical trials: Maybe European research should be protected. BMJ 2004; 329:1044
36. Bassand JP, Martin J, Rydén L, et al: The need for resources for clinical research: The European Society of Cardiology calls for European, international collaboration. Lancet 2002; 360:1866 -1869
37. Remuzzi G, Schieppati A, Boissel JP, et al: Independent clinical research in Europe. Lancet 2004; 364:1723-1726
38. Hearn J, Sullivan R: The impact of the Clinical Trials directive on the cost and conduct of non-commercial cancer trials in the UK. Eur J Cancer 2007; 43:8-13
39. Available at: http://www.ecrin.org. Accessed December 2007
40. Bell J: Resuscitating clinical research in the United Kingdom. BMJ 2003; 327:1041-1043
41. GlaxoSmithKline: GlaxoSmithKline settles litigation with New York Attorney General's Office. Press release, 26 August 2004. Available at: http://www.gsk.com/press-archive/ press2004/press-08262004.pdf. Accessed December 2007
42. Office of Attorney General, New York. Settlement sets new standard for release of drug information. Available at: http://www.oag. state.ny.us/press/ 2004/aug/aug26a-04.html. Accessed December 2007
43. Sim I, Detmer DE: Beyond trial registration: A global trial bank for clinical trial reporting. PLoS Med 2005; 2:e365